Abstract:The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global health emergency, and its gene mutation and evolution further posed uncertainty of epidemic risk. Herein, we reported a light-up CRISPR-Cas13 transcription amplification method, which enables the detection of SARS-CoV-2 and its mutated variants. Sequence specificity was ensured by both the ligation process and Cas13a/crRNA recognition, allowing us to identify viral RNA mutation. Light-up RNA aptamer allows sensitive output of amplification signals via target-activated ribonuclease activity of CRISPR-Cas13a. The RNA virus assay has been designed to detect coronavirus, SARS-CoV-2, Middle East respiratory syndrome (MERS), and SARS, as well as the influenza viruses such as, H1N1, H7N9, and H9N2. It was accommodated to sense as low as 82 copies of SARS-CoV-2. Particularly, it allowed us to strictly discriminate key mutation of the SARS-CoV-2 variant, D614G, which may induce higher epidemic and pathogenetic risk. The proposed RNA virus assays are promising for point-of-care monitoring of SARS-CoV-2 and its risking variants.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04303?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04303</a>.Oligonucleotide sequences; different assays for the detection of SARS-CoV-2; gene sequences of SARS-CoV-2 (wild), SARS-CoV-2 (D614G mutated), SARS and MERS pseudovirus; plasmid vector for constructing pseudovirus; working flow to prepare SARS-CoV-2 contaminated food packages and frozen belt fish samples; detection of E gene of coronavirus species; the effect of locus sites of mutation on the specificity; the effect of recognition sequences of mutation on the specificity; discrimination rates via ligation-based recognition or the integration of ligation and Cas13/crRNA recognition; optimization of the ratio of Cas13a to crRNA; real-time analysis of Cas13a-crRNA induced cleavage of light-up RNA aptamer; amplification curves of N genes of SARS-CoV-2 from clinical throat swab samples; and sequencing of SARS-CoV-2 in clinical throat swab samples (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04303/suppl_file/ac0c04303_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis

Rapid detection of the SARS-CoV-2 omicron variants based on high-resolution melting curve analysis

Genotyping of the Major SARS-CoV-2 Clade by Short-Amplicon High-Resolution Melting (SA-HRM) Analysis

Genotyping coronavirus SARS-CoV-2: methods and implications

Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern

Universal Exponential Amplification Confers Multilocus Detection of Mutation-Prone Virus

Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern

Rapid Detection of Predominant SARS-CoV-2 Variants Using Multiplex High-Resolution Melting Analysis

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Fluorometric Detection of SARS-CoV-2 Single-Nucleotide Variant L452R Using Ligation-Based Isothermal Gene Amplification

Rapid and Accurate Detection of Three Genes in SARS-CoV-2 Using RT-LAMP Method

A novel assay based on DNA melting temperature for multiplexed identification of SARS-CoV-2 and influenza A/B viruses

A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2

Detection of SARS-CoV-2 and Its Mutated Variants via CRISPR-Cas13-Based Transcription Amplification

An encodable multiplex microsphere-phase amplification sensing platform detects SARS-CoV-2 mutations

Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay

Identification of the SARS-CoV-2 Delta variant C22995A using a high-resolution melting curve RT-FRET-PCR

Genome-Wide Identification and Characterization of Point Mutations in the SARS-CoV-2 Genome

Rapid and accurate detection of SARS-CoV-2 mutations using a Cas12a-based sensing platform

Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations

High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples